3-Methoxytyramine

CAS No. 554-52-9

3-Methoxytyramine( —— )

Catalog No. M21424 CAS No. 554-52-9

3-Methoxytyramine a well known extracellular metabolite of 3-hydroxytyramine/dopamine is a neuromodulator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 41 In Stock
50MG 30 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-Methoxytyramine
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Methoxytyramine a well known extracellular metabolite of 3-hydroxytyramine/dopamine is a neuromodulator.
  • Description
    3-Methoxytyramine a well known extracellular metabolite of 3-hydroxytyramine/dopamine is a neuromodulator.
  • In Vitro
    ——
  • In Vivo
    The extracellular dopamine (DA) metabolite 3-methoxytyramine (3-MT) induces significant behavioral activation in dopamine-deficient DAT-KO (DDD) mice. 3-Methoxytyramine induces behavioral activation and intracellular signaling in the striatum of DA deficient mice.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    554-52-9
  • Formula Weight
    167.21
  • Molecular Formula
    C9H13NO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:12.5 mg/mL (74.76 mM; Need ultrasonic);H2O:2 mg/mL (11.96 mM; Need ultrasonic)
  • SMILES
    COc(cc(CCN)cc1)c1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sotnikova TD et al. The dopamine metabolite 3-methoxytyramine is a neuromodulator. PLoS One. 2010 Oct 18;5(10):e13452. doi: 10.1371/journal.pone.0013452.
molnova catalog
related products
  • Emitefur

    Emitefur (BOF-A 2) is an orally active and potent 5-fluorouracil derivative with anticancer and antitumor activity.

  • Bosutinib hydrate

    Bosutinib (hydrate) is an oral Src/Abl tyrosine kinase inhibito with IC50 of 1.2 nM and 1 nM, respectively.

  • Ac - 5A/5B Peptide

    Ac - 5A/5B Peptide